A Prospective Study of Clinical Outcomes for the Pathwork Tissue of Origin Test

A Prospective Study of Clinical Outcomes for the Pathwork® Tissue of Origin Test

The study prospectively assesses the change in cancer-specific clinical decisions and outcomes before and after physicians received results from the Pathwork® Tissue of Origin (TOO) Test for patients whose primary site of cancer origin is uncertain.

Inclusion Criteria:

• their physician ordered or intends to order a Pathwork® TOO Test between May 2012 and December 2013
• the patient is ≥ 18 years of age
• the patient has given informed consent (online or verbal)
• the patient is able to understand English.